| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | OCEA | Common Stock, par value $0.0001 | Other | +21.3K | 21.3K | Feb 28, 2023 | By Sansur Associates, LLC | F1, F2, F3 | |||
| holding | OCEA | Common Stock, par value $0.0001 | 469K | Feb 28, 2023 | By Surendra Ajjarapu Revocable Trust of 2007 | F4 | |||||
| holding | OCEA | Common Stock, par value $0.0001 | 258K | Feb 28, 2023 | By Sandhya Ajjarapu Revocable Trust of 2007 | F5 | |||||
| holding | OCEA | Common Stock, par value $0.0001 | 1.37M | Feb 28, 2023 | By Aesther Healthcare Sponsor, LLC | F6, F7 |
Surendra K. Ajjarapu is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.
| Id | Content |
|---|---|
| F1 | This Form 4/A is being filed jointly by Aesther Healthcare Sponsor, LLC (the "Sponsor") and Suren Ajjarapu ("Mr. Ajjarapu") to amend the previous Form 4 filed by the Sponsor and Mr. Ajjarapu on March 2, 2023 (the "Prior Form 4"). The purpose of this Form 4/A is to: (i) report a previously omitted acquisition of common stock, par value $0.0001 per share (the "Common Stock"), of Ocean Biomedical, Inc. (the "Issuer") by Sansur Associates, LLC ("Sansur"), which Mr. Ajjarapu may be deemed to have an indirect beneficial interest in; (ii) correct the footnote disclosures related to the trustees of the Surendra Ajjarapu Revocable Trust of 2007 (the "Surendra Trust") and the Sandhya Ajjarapu Revocable Trust of 2007 (the "Sandhya Trust"); and (iii) report that, following the Distribution (defined in footnote 2 below), the Sponsor no longer holds more than 10% of any class of the Issuer's securities. |
| F2 | As disclosed in the Prior Form 4, on February 28, 2023, the Sponsor made a distribution for no consideration of 2,625,000 shares of Common Stock to certain of its members (the "Distribution"), including the Surendra Trust and the Sandhya Trust. This Form 4/A is being filed to report that as part of the Distribution, the Sponsor also distributed 21,252 shares to Sansur Associates, LLC ("Sansur"), of which Mr. Ajjarapu is the manager. The 21,252 shares of Common Stock distributed to Sansur and Mr. Ajjarapu's indirect beneficial interest therein were inadvertently omitted from the Prior Form 4. |
| F3 | These shares of Common Stock are owned directly by Sansur. As manager of Sansur, Mr. Ajjarapu may be deemed to be the indirect beneficial owner of the securities held by Sansur. Mr. Ajjarapu disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
| F4 | These shares of Common Stock are owned directly by the Surendra Trust. The Prior Form 4 reported that Mr. Ajjarapu's wife, Sandhya Ajjarapu ("Mrs. Ajjarapu"), is the trustee of the Surendra Trust. In fact, Mr. Ajjarapu is the trustee and, in such capacity, is deemed to be the indirect beneficial owner of the shares held by the Surendra Trust. The updated disclosure of the Surendra Trust's reported trustee in this Form 4/A does not change the extent of Mr. Ajjarapu's indirect interest in the Surendra Trust that was reported in the Prior Form 4. |
| F5 | These shares of Common Stock are owned directly by the Sandhya Trust. The Prior Form 4 reported that Mr. Ajjarapu is the trustee of the Sandhya Trust. In fact, Mrs. Ajjarapu is the trustee. Because Mrs. Ajjarapu's pecuniary interest in the Sandhya Trust is attributable to Mr. Ajjarapu by nature of their spousal relationship, Mr. Ajjarapu is deemed to be the indirect beneficial owner of the shares held by the Sandhya Trust. The updated disclosure of the Sandhya Trust's reported trustee in this Form 4/A does not change the extent of Mr. Ajjarapu's indirect interest in the Sandhya Trust that was reported in the Prior Form 4. |
| F6 | Following the Distribution, the Sponsor no longer holds more than 10% of any class of the Issuer's securities and is therefore no longer a reporting person for purposes of Section 16 of the Securities Exchange Act of 1934, as amended. |
| F7 | These shares are owned directly by the Sponsor. Mr. Ajjarapu is the managing member of the Sponsor and therefore may be deemed to have beneficial ownership of the securities held by the Sponsor. Mr. Ajjarapu disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. |
Exhibit List - Exhibit 24.1: Power of Attorney (Surendra K. Ajjarapu) Exhibit 24.2: Power of Attorney (Aesther Healthcare Sponsor, LLC)